Loading...
Myrexis, Inc.
MYRX•PNK
Financial ServicesShell Companies
$0.00
$0.00(0.00%)
Myrexis, Inc. (MYRX) Stock Overview
Explore Myrexis, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for MYRXStats details for MYRX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for MYRXAnalyst Recommendations details for MYRX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
CEO
Mr. Jonathan M. Couchman CFA
Employees
1
Headquarters
630 Fifth Avenue, New York City, NY
Founded
2009